Načítá se...
A Modifying Autoantigen in Graves’ Disease
The TSH receptor (TSHR) is the major autoantigen in Graves’ disease (GD). Bioinformatic analyses predict the existence of several human TSHR isoforms from alternative splicing, which can lead to the coexpression of multiple receptor forms. The most abundant of these is TSHRv1.3. In silico modeling o...
Uloženo v:
| Vydáno v: | Endocrinology |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Endocrine Society
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455603/ https://ncbi.nlm.nih.gov/pubmed/30822352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2018-01048 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|